quinazolines has been researched along with bilirubin in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (28.57) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 4 (57.14) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ochiai, T | 1 |
| Conti, M; Guerci, R; Setnikar, I | 1 |
| Karasawa, A; Kusaka, H; Nishikawa, S; Noji, T; Sano, J; Sato, H | 1 |
| House, L; Liu, Y; Ramírez, J; Ratain, MJ | 1 |
| Bertucci, C; Felix, G; Fortugno, C; Gil, C; Martinez, A; Palomo, V; Pérez, DI; Pistolozzi, M; Redondo, M | 1 |
| Burns, K; Chau, N; Kichenadasse, G; Knights, KM; Mackenzie, PI; McKinnon, RA; Miners, JO; Rowland, A; Tucker, GT | 1 |
| Gao, H; Hu, C; Liu, R; Qin, L; Su, D; Wang, G; Yang, C; Yang, X; Yang, Y; Yu, M; Zhou, Y | 1 |
7 other study(ies) available for quinazolines and bilirubin
| Article | Year |
|---|---|
Effects of 1-morpholinoacetyl-2-methyl-3-phenyl-4-oxo-1,2,3,4-tetrahydro quinazoline hydrochloride (HQ-275) on alpha-naphtyl isothio-cyanate- and/or thioacetamide-induced liver damage in rats.
Topics: Acetamides; Adenosine Triphosphatases; Alanine Transaminase; Animals; Aspartate Aminotransferases; Bile; Bilirubin; Body Temperature; Chemical and Drug Induced Liver Injury; Cholesterol; Histocytochemistry; Liver; Male; Morpholines; Potassium; Quinazolines; Rats; Sodium; Thioacetamide; Thiocyanates; Time Factors; Water | 1974 |
Pharmacology of moquizone, a new choleretic drug.
Topics: Animals; Bile; Bile Acids and Salts; Bilirubin; Cats; Cholagogues and Choleretics; Cholesterol; Dehydrocholic Acid; Diuresis; Dogs; Duodenum; Gallbladder; Guinea Pigs; Hemodynamics; Injections; Injections, Intravenous; Lethal Dose 50; Mice; Morpholines; Muscle, Smooth; Quinazolines; Rabbits; Rats; Tetracycline | 1972 |
Treatment with an adenosine uptake inhibitor attenuates glomerulonephritis in mice.
Topics: Adenosine; Alanine Transaminase; Animals; Anti-Inflammatory Agents; Bilirubin; Cyclophosphamide; Erythrocyte Count; Glomerular Mesangium; Glomerulonephritis; Immunosuppressive Agents; Kidney Function Tests; Kidney Tubules; Male; Mice; Neurotransmitter Uptake Inhibitors; Organ Size; Periodic Acid-Schiff Reaction; Prednisolone; Pyrimidinones; Quinazolines; Rabbits; Spleen; Thymus Gland | 2002 |
Comparison of the drug-drug interactions potential of erlotinib and gefitinib via inhibition of UDP-glucuronosyltransferases.
Topics: Adolescent; Adult; Aged; Area Under Curve; Bilirubin; Binding, Competitive; Biocatalysis; Cell Line; Child; Drug Interactions; Erlotinib Hydrochloride; Female; Gefitinib; Glucuronic Acid; Glucuronosyltransferase; Humans; Hymecromone; Imipramine; Indinavir; Isoenzymes; Kinetics; Male; Microsomes, Liver; Middle Aged; Models, Biological; Protein Kinase Inhibitors; Quinazolines; Recombinant Proteins; Young Adult | 2010 |
5-Imino-1,2-4-thiadiazoles and quinazolines derivatives as glycogen synthase kinase 3β (GSK-3β) and phosphodiesterase 7 (PDE7) inhibitors: determination of blood-brain barrier penetration and binding to human serum albumin.
Topics: Animals; Bilirubin; Binding Sites; Biological Transport; Blood-Brain Barrier; Cell Membrane Permeability; Chromatography, High Pressure Liquid; Circular Dichroism; Cyclic Nucleotide Phosphodiesterases, Type 7; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Humans; Membranes, Artificial; Protein Binding; Quinazolines; Serum Albumin; Swine; Thiadiazoles | 2012 |
Inhibition of human UDP-glucuronosyltransferase enzymes by lapatinib, pazopanib, regorafenib and sorafenib: Implications for hyperbilirubinemia.
Topics: Bilirubin; Catalysis; Enzyme Inhibitors; Glucuronosyltransferase; Humans; Hyperbilirubinemia; Indazoles; Kinetics; Lapatinib; Microsomes, Liver; Niacinamide; Phenylurea Compounds; Pyridines; Pyrimidines; Quinazolines; Sorafenib; Sulfonamides | 2017 |
D-T7 Peptide-Modified PEGylated Bilirubin Nanoparticles Loaded with Cediranib and Paclitaxel for Antiangiogenesis and Chemotherapy of Glioma.
Topics: Animals; Bilirubin; Blood-Brain Barrier; Brain Neoplasms; Cell Line, Tumor; Collagen Type IV; Drug Carriers; Glioma; Humans; Male; Mice; Nanoparticles; Paclitaxel; Peptide Fragments; Quinazolines | 2019 |